|
|
|
|
Gene Editing Offers Dual Protection Against PRV and PRRSV |
|
|
|
A research team from Northwest A&F University and partners examined the effectiveness of a recombinant Pseudorabies Virus (PRV) in addressing challenges posed by Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) and PRV in the pig industry. The findings provide significant insights into the development of vaccines and future prevention and control of NADC30-like PRRSV and PRV.
|
|
|
|
|
Infant is World's First Patient Treated with Customized CRISPR Gene Editing Therapy |
|
|
|
In a historic breakthrough, a child with a rare and life-threatening condition became the first person to receive a customized CRISPR gene editing therapy by a team at the Children's Hospital of Philadelphia (CHOP) and Penn Medicine. The treatment is the first of its kind designed to correct a disease-causing mutation found only in that individual.
|
|
|
|
|
|
|
|
A biweekly update on gene editing research, regulations, and impact
produced by ISAAA Inc. |
| |
|
|
|
| A monthly update on gene drive research and development provided by ISAAA in collaboration with the Outreach Network for Gene Drive Research |
| |
|
|
|
|
GM APPROVAL UPDATES |
- The Philippines approved the canola event LBFLFK for food, feed, and processing.
- The Philippines approved the cotton event GFM cry1A for commercial cultivation.
- Brazil approved the wheat event HB4 for commercial cultivation.
- The Philippines approved the soybean event GMB 151 for food, feed, and processing.
- The Philippines approved the eggplant event EE-1 for cultivation
- The USA approved the canola event MON94100 for food and feed.
|
|
|
|
| Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10. |
|
|
|
|
